People with multiple sclerosis had high use of telehealth during the pandemic
MS Patients Show Robust T-Cell Response to mRNA COVID-19 Vaccines
MS patients receiving anti-CD20 monoclonal antibody treatment can still mount T-cell responses
Greater Disability Tied to Worse COVID-19 Severity in MS Patients
Risk for hospitalization, ICU admission/ventilator support, death increased in multiple sclerosis patients with ambulatory disability, older age